Dalazatide (ShK-186) TFA, a precise Kv1.3 potassium channel peptide inhibitor, is employed in researching autoimmune conditions, including multiple sclerosis (MS), lupus erythematosus, psoriasis, rheumatoid arthritis, type 1 diabetes, and inflammatory bo
Molecular Weight:
4556.1
Formula:
C186H297F3N57PS7
* VAT and and shipping costs not included. Errors and price changes excepted